# Vernal Biosciences, Inc. — Form D/A

Vernal Biosciences, Inc. of Colchester, VT, a company, filed a Form D amendment with the SEC on 2023-06-16. The offering totals $41.0M, of which $41.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-06-16
- Form: D/A
- Accession: 0001861147-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $41.0M
- Amount sold: $41.0M
- Investors: 10
- Date of first sale: 2022-05-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-446902

## Issuer

- Name: Vernal Biosciences, Inc.
- CIK: 0001861147
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 261 Mountain View Drive, Colchester, VT, 05461
- Phone: 512-791-9680

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| David Anderson | Director | Calgary, A0 |
| Christian Cobaugh | Director | Colchester, VT |
| Daniella Kranjac | Director | New York, NY |
| Christian Cobaugh | Executive Officer | Colchester, VT |
| Errik Anderson | Director | Cambridge, MA |
| Gustavo Mahler | Director | Colchester, VT |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-05-25](https://search.stillhousedata.com/formd/0001861147-22-000002) | D | $21.0M | $21.0M |
| [2021-05-24](https://search.stillhousedata.com/formd/0001861147-21-000001) | D | $1.5M | $1.5M |

## More

- [CIK 1861147 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1861147&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001861147-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.